health Neurologists Issue Urgent Warning on GLP-1 Drugs for ALS Patients
New evidence reveals that the rapid weight loss caused by GLP-1 agonists like Ozempic and Wegovy may dangerously accelerate the progression of neurodegenerative diseases such as ALS.
